Guardion Health: Rises on launch of supplement for immune support
** Shares of medical device and supplement maker GHSI.O
rise 6.5% to 50 cents
** Co says its nutraceutical formulation, acuMMUne, is now
commercially available urn:newsml:reuters.com:*:nGNX4RsQ7W
** GHSI says the supplement was formulated with ingredients
that have been shown in studies to support important components
of the body's immune response during viral infections
** However, GHSI says its claims are not evaluated by the
U.S. FDA and that the product is not intended to diagnose, treat
or prevent any disease
** Shares have more than doubled YTD
(Reporting by Manas Mishra in Bengaluru)
((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780,
outside U.S. +91 806749 2709))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview